Myocardial infarction (MI) is still the leading cause of mortality worldwide. The success of cell-
based therapies and tissue engineering strategies for treatment of injured myocardium have …

The development of biomaterials for cardiac tissue engineering (CTE) is challenging,
primarily owing to the requirement of achieving a surface with favourable characteristics that …

Background: Human induced pluripotent stem cells with normal (wild-type) or upregulated
(overexpressed) levels of CCND2 (cyclin D2) expression were differentiated into …

The desire and need to minimize traditional open surgeries is gearing up as it could reduce
the healthcare expenses and improve the recovery time for the patients. Minimal invasive …

Once myocardium dies during a heart attack, it is replaced by scar tissue over the course of
several weeks. The size, location, composition, structure and mechanical properties of the …

Cardiac tissue damage due to myocardial infarction (MI) is one of the leading causes of
mortality worldwide. The available treatments of MI include pharmaceutical therapy, medical …

Myocardial tissue lacks the ability to significantly regenerate itself following a myocardial
infarction, thus tissue engineering strategies are required for repair. Several injectable …

Objectives: This study evaluated the use of an injectable hydrogel derived from ventricular
extracellular matrix (ECM) for treating myocardial infarction (MI) and its ability to be delivered …

Minimally invasive intervention strategies after myocardial infarction use state‐of‐the‐art
catheter systems that are able to combine mapping of the infarcted area with precise, local …

Despite the success of current therapies for acute myocardial infarction (MI), many patients
still develop adverse cardiac remodeling and heart failure. With the growing prevalence of …